NRXS

Neuraxis Stock Analysis

AI Rating

Neutral
  • Quality8/10
  • Growth↑ 7/10
  • Value↓ 0/10
Neuraxis sales and earnings growth
NRXS Growth
Good
  • Revenue Y/Y↑ 32.89%
  • EPS Y/Y↑ 22.13%
  • FCF Y/Y↓ -7.15%
Neuraxis gross and profit margin trends
NRXS Profitability
Neutral
  • Gross margin ↑ 84.20%
  • EPS margin↓ -241.40%
  • ROIC 5Y↑ 0.00%
Neuraxis net debt vs free cash flow
NRXS Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -104.5

Neuraxis stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks